Objective : Ahmed Usman, Heeranand Keswani, Suresh Nagdev, Ghulam Haider, Tehseen Khursheed, Anis Malik, Kasif Jafferi To evaluate the nephrotoxicity of cisplatiri in cancer patients, using different protocols of hydration.
Study Design : Randomized controlled trial.
Patients & Methods : This study was conducted between 1st June to 30th November 2004. Ninetynine patients with normal renal function were enrolled in the study and randomly assigned into the 3 study groups, each group having 33patients. In group 1 hydration was done with saline (2 liter) alone, in group 2 with saline (2 liter) and furosemide (40mg) and in group 3 with saline (2 liter) and mannitol (100ml). All 3group patients were given cisplatin infusion 100 mg/m2 over 1 hour and the cycles repeated every 21-28 days. Twenty four hour creatinine clearance was measured before and after 6th day of the chemotherapy in all patients.
Results: For the first cycle of chemotherapy the 24-hour urinary creatinine clearance before chemotherapy for saline group was 95.54+/- 15.27, for saline and furosemide group 98.43+/ - 13.44 and for saline and mannitol group 97.45+/ - 14.05 ml/ min and after 6th day of cisplatin infusion was 77.4+/-14.59 for saline group, 86.06+/-11.9 for saline and furosemide group and 82.29+/- 13.64 for saline and mannitol group. The reduction in creatinine clearance was less with saline and furosemide group (12.6%) as compared to saline and mannitol group (15.6%) and saline alone (18.9%) which is statistically significant. Each patient in these 3 study groups received many courses of cisplaiiri and showed the similar pattern.
Conclusions : Hydration with saline and furosemide isless nephrotoxic than other protocols with cisplatin infusion.
JSP: Journal of Surgery Paksitan.
(2006). CISPLATIN NEPHROTOXICITY AND HYDRATION PROTOCOLS. JSP: Journal of Surgery Paksitan., 11(1), 1-45.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_med/583